Image data is challenging to manage and store for pharmaceutical companies, especially when they need to share it for licensing, acquisition, or due diligence.

Image analysis is often a key endpoint for demonstrating the efficacy of a drug. However, without proper data warehousing, reproducing the results and proving the value of the drug can be challenging. Reproducibility is essential for providing hard evidence to regulators and investors.